SUNRISE TECHNOLOGIES INTERNATIONAL INC
8-K, 1999-03-12
DENTAL EQUIPMENT & SUPPLIES
Previous: CHILE FUND INC, SC 13G/A, 1999-03-12
Next: WM TRUST II, 485BPOS, 1999-03-12





                  SECURITIES AND EXCHANGE COMMISSION

                        Washington, D.C. 20549



                               FORM 8-K

                            CURRENT REPORT

                Pursuant to Section 13 or 15(d) of the
                    Securities Exchange Act of 1934




Date of Report (Date of earliest event reported)      March 10, 1999




               SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
        ------------------------------------------------------
        (Exact name of registrant as specified in its charter)




   Delaware                    1-10428               77-0148208
- ------------------          ------------           ---------------
(State of or other          (Commission            (IRS Employer
jurisdiction of             File Number)           Identification
incorporation)                                     Number)



3400 West Warren Avenue, Fremont, California               94538
- --------------------------------------------            ----------
  (Address of principal executive offices)              (Zip Code)





Registrant's telephone number, including area code    (510) 623-9001




        ------------------------------------------------------
        (Former name or address, if changed since last report)


<PAGE>


ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.

         99.1  Press Release of the Company dated March 10, 1999.







                              SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.


                            SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
                            (Registrant)


DATE:  March 12, 1999       By:   /s/ C. Russell Trenary, III
                                  ----------------------------------
                                  Name:   C. Russell Trenary, III
                                  Title:  President and 
                                          Chief Executive Officer



SUNRISE TECHNOLOGIES                                       EXHIBIT 99.1

                                                  FOR IMMEDIATE RELEASE


CONTACT:         Investor Relations
Susan Lorigan    (510) 623-9001
Ed Coghlan       (510) 771-2399


               SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
                        ANNOUNCES RESTRUCTURING


FREMONT, CALIFORNIA, MARCH 10, 1999 -- SUNRISE TECHNOLOGIES INTERNATIONAL,
INC. (NASDAQ/NMS: SNRS) - today announced Timothy A. Marcotte's employment
as Vice President and Chief Financial Officer has been severed.  Ms. Tina
Herbert, the Company's Controller, has been appointed acting Vice President
Finance and Chief Financial Officer.  In addition, Ms. Sylvia Ward has been
appointed the Company's acting Controller.  C. Russell Trenary, III, the
Company's Chief Executive Officer and President, said, "Ms. Herbert and Ms.
Ward will be able to advance the Company's plans efficiently and
expeditiously."

In addition, the Company announced it has engaged Phillip E. Meade of
Laguna Group to direct, lead and coordinate activities in the human
resources function.  The Company anticipates substantial growth in the
employee base as it continues planning the launch of its
Hyperion<trademark> LTK System.  Mr. Meade has acted in the capacity of
Vice President of Human Resources for various companies including American
Hospital Supply in Deerfield, Illinois; Baxter International in Deerfield,
Illinois; and MedLogic Global Corporation in Colorado Springs.

Founded in 1987, the Company produces and markets high technology products
revolutionizing treatment methods in eye care.  The Company develops
Holmium laser-based systems, which utilize a patented process for shrinking
collagen developed by Dr. Bruce Sand (the "Sand Process") in correcting
ophthalmic conditions.  These Systems* incorporate a non-contact
simultaneous application for correction of hyperopia (farsightedness),
presbyopia (loss of focus due to natural aging), and overcorrection
resulting from PRK and LASIK treatments for myopia. The system is currently
in use in Europe and the Americas, and is in clinical trials in the United
States.



<PAGE>


Except for historical information, this news release contains certain
forward-looking statements that involve risk and uncertainties which may
cause actual results to differ materially from the statements made,
including market potential, regulatory clearances, business growth and
other risks listed from time to time in the Company's Securities and
Exchange Commission (SEC) filings.  These forward-looking statements
represent the Company's judgment, as of the date of this release, and the
Company disclaims any intent or obligation to update these forward-looking
statements.

*Caution-Investigational Device:  Federal law restricts this device to
investigational use in the U.S. Internet users can access Sunrise's World
Wide Web site at http://www.sunrise-tech.com.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission